Product nameAnti-Neurotensin Receptor 1/NTSR1 antibody
See all Neurotensin Receptor 1/NTSR1 primary antibodies
DescriptionGuinea pig polyclonal to Neurotensin Receptor 1/NTSR1
Host speciesGuinea pig
Tested applicationsSuitable for: WB, IHC-Fr, ICC/IFmore details
Species reactivityReacts with: Rat
Predicted to work with: Mouse
This product was previously labelled as Neurotensin Receptor 1
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferConstituent: Whole serum
Our Abpromise guarantee covers the use of ab66216 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/5000. Detects a band of approximately 47 kDa (predicted molecular weight: 47 kDa).|
RelevanceNeurotensin receptor 1 belongs to the large superfamily of G-protein coupled receptors. NTSR1 mediates the multiple functions of neurotensin, such as hypotension, hyperglycemia, hypothermia, antinociception, and regulation of intestinal motility and secretion. NTR1 has been reported in brain, pancreas, and small intestine. ESTs have been isolated from brain and colon libraries.
Cellular localizationCell Membrane, Endoplasmic reticulum, Golgi Apparatus and Plasma membrane. Integral membrane protein.
- High affinity levocabastine insensitive neurotensin receptor antibody
- Neurotensin receptor 1 (high affinity) antibody
- Neurotensin receptor type 1 antibody
Top image: Light microscopic analysis of NTSR1 expression in primary afferent neurons (arrows) using 1:1000 ab66216 of PFA fixed cells.
Bottom image: At higher magnification, neurons exhibit a cytoplasmic pattern of immunoreactivity (arrowheads).
All lanes : Anti-Neurotensin Receptor 1/NTSR1 antibody (ab66216) at 1/5000 dilution
Lane 1 : DRG's
Lane 2 : Lumbar spinal chord
Lane 3 : brain
Lysates/proteins at 25 µg per lane.
Predicted band size: 47 kDa
Observed band size: 47 kDa
ab66216 has not yet been referenced specifically in any publications.